Zhanghua Chen1, Muhammad T Salam1,2, Tanya L Alderete1, Rima Habre1, Theresa M Bastain1, Kiros Berhane3, Frank D Gilliland1. 1. 1 Department of Preventive Medicine, Division of Environmental Health and. 2. 2 Department of Psychiatry, Kern Medical Center, Bakersfield, California. 3. 3 Department of Preventive Medicine, Division of Biostatistics, Keck School of Medicine of University of Southern California, Los Angeles, California; and.
Abstract
RATIONALE: Asthma and obesity often occur together in children. It is unknown whether asthma contributes to the childhood obesity epidemic. OBJECTIVES: We aimed to investigate the effects of asthma and asthma medication use on the development of childhood obesity. METHODS: The primary analysis was conducted among 2,171 nonobese children who were 5-8 years of age at study enrollment in the Southern California Children's Health Study (CHS) and were followed for up to 10 years. A replication analysis was performed in an independent sample of 2,684 CHS children followed from a mean age of 9.7 to 17.8 years. MEASUREMENTS AND MAIN RESULTS: Height and weight were measured annually to classify children into normal, overweight, and obese categories. Asthma status was ascertained by parent- or self-reported physician-diagnosed asthma. Cox proportional hazards models were fitted to assess associations of asthma history with obesity incidence during follow-up. We found that children with a diagnosis of asthma at cohort entry were at 51% increased risk of developing obesity during childhood and adolescence compared with children without asthma at baseline (hazard ratio, 1.51; 95% confidence interval, 1.08-2.10) after adjusting for confounders. Use of asthma rescue medications at cohort entry reduced the risk of developing obesity (hazard ratio, 0.57; 95% confidence interval, 0.33-0.96). In addition, the significant association between a history of asthma and an increased risk of developing obesity was replicated in an independent CHS sample. CONCLUSIONS: Children with asthma may be at higher risk of obesity. Asthma rescue medication use appeared to reduce obesity risk independent of physical activity.
RATIONALE: Asthma and obesity often occur together in children. It is unknown whether asthma contributes to the childhood obesity epidemic. OBJECTIVES: We aimed to investigate the effects of asthma and asthma medication use on the development of childhood obesity. METHODS: The primary analysis was conducted among 2,171 nonobese children who were 5-8 years of age at study enrollment in the Southern California Children's Health Study (CHS) and were followed for up to 10 years. A replication analysis was performed in an independent sample of 2,684 CHSchildren followed from a mean age of 9.7 to 17.8 years. MEASUREMENTS AND MAIN RESULTS: Height and weight were measured annually to classify children into normal, overweight, and obese categories. Asthma status was ascertained by parent- or self-reported physician-diagnosed asthma. Cox proportional hazards models were fitted to assess associations of asthma history with obesity incidence during follow-up. We found that children with a diagnosis of asthma at cohort entry were at 51% increased risk of developing obesity during childhood and adolescence compared with children without asthma at baseline (hazard ratio, 1.51; 95% confidence interval, 1.08-2.10) after adjusting for confounders. Use of asthma rescue medications at cohort entry reduced the risk of developing obesity (hazard ratio, 0.57; 95% confidence interval, 0.33-0.96). In addition, the significant association between a history of asthma and an increased risk of developing obesity was replicated in an independent CHS sample. CONCLUSIONS:Children with asthma may be at higher risk of obesity. Asthma rescue medication use appeared to reduce obesity risk independent of physical activity.
Authors: Muhammad T Salam; W James Gauderman; Rob McConnell; Pi-Chu Lin; Frank D Gilliland Journal: Am J Respir Crit Care Med Date: 2007-08-02 Impact factor: 21.405
Authors: Robert Urman; Rob McConnell; Talat Islam; Edward L Avol; Frederick W Lurmann; Hita Vora; William S Linn; Edward B Rappaport; Frank D Gilliland; W James Gauderman Journal: Thorax Date: 2013-11-19 Impact factor: 9.139
Authors: Frank D Gilliland; Kiros Berhane; Talat Islam; Rob McConnell; W James Gauderman; Susan S Gilliland; Edward Avol; John M Peters Journal: Am J Epidemiol Date: 2003-09-01 Impact factor: 4.897
Authors: Danielle R Stevens; William Grobman; Rajesh Kumar; Leah M Lipsky; Stefanie N Hinkle; Zhen Chen; Andrew Williams; Matthew C H Rohn; Jenna Kanner; Seth Sherman; Pauline Mendola Journal: Am J Epidemiol Date: 2021-05-04 Impact factor: 4.897
Authors: Zhanghua Chen; Megan M Herting; Leda Chatzi; Britni R Belcher; Tanya L Alderete; Rob McConnell; Frank D Gilliland Journal: Am J Clin Nutr Date: 2019-01-01 Impact factor: 7.045